Healthcare provider profile · identity verified

Mark D Hingst, M.D.

Family Practice · SAINT PETERS, MO · NPI 1053372847

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	735	196
Losartan Potassium	Losartan Potassium	513	144
Levothyroxine Sodium	Levothyroxine Sodium	506	124
Lisinopril	Lisinopril	415	116
Metformin Hcl	Metformin Hcl	412	114
Amlodipine Besylate	Amlodipine Besylate	410	116
Metoprolol Succinate	Metoprolol Succinate	390	114
Simvastatin	Simvastatin	375	99
Hydrochlorothiazide	Hydrochlorothiazide	374	110
Pantoprazole Sodium	Pantoprazole Sodium	374	111
Rosuvastatin Calcium	Rosuvastatin Calcium	308	84
Tramadol Hcl	Tramadol Hcl	285	58
Tamsulosin Hcl	Tamsulosin Hcl	284	90
Alprazolam	Alprazolam	269	71
Omeprazole	Omeprazole	263	71
Pravastatin Sodium	Pravastatin Sodium	253	65
Allopurinol	Allopurinol	251	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	241	67
Glimepiride	Glimepiride	216	62
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	209	55
Gabapentin	Gabapentin	200	63
Zolpidem Tartrate	Zolpidem Tartrate	197	55
Furosemide	Furosemide	195	53
Celecoxib	Celecoxib	186	68
Arexvy	Rsvpref3 Antigen/As01e/Pf	174	173
Sertraline Hcl	Sertraline Hcl	166	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	155	42
Albuterol Sulfate Hfa	Albuterol Sulfate	150	57
Metoprolol Tartrate	Metoprolol Tartrate	147	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	139	71
Citalopram Hbr	Citalopram Hydrobromide	130	35
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	125	29
Fluticasone Propionate	Fluticasone Propionate	120	52
Tizanidine Hcl	Tizanidine Hcl	112	38
Fluoxetine Hcl	Fluoxetine Hcl	111	29
Meloxicam	Meloxicam	110	38
Memantine Hcl	Memantine Hcl	110	20
Eliquis	Apixaban	109	31
Famotidine	Famotidine	107	29
Trazodone Hcl	Trazodone Hcl	107	33
Potassium Chloride	Potassium Chloride	105	32
Finasteride	Finasteride	97	29
Lovastatin	Lovastatin	96	25
Carvedilol	Carvedilol	93	25
Clopidogrel	Clopidogrel Bisulfate	92	25
Atenolol	Atenolol	91	26
Cefuroxime	Cefuroxime Axetil	90	85
Lorazepam	Lorazepam	87	20
Januvia	Sitagliptin Phosphate	81	15
Donepezil Hcl	Donepezil Hcl	80	16
Naproxen	Naproxen	79	25
Diazepam	Diazepam	77	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	20
Fenofibrate	Fenofibrate	68	20
Alendronate Sodium	Alendronate Sodium	66	19
Ozempic	Semaglutide	65	14
Ezetimibe	Ezetimibe	64	20
Escitalopram Oxalate	Escitalopram Oxalate	63	19
Xarelto	Rivaroxaban	63	14
Jardiance	Empagliflozin	62	20
Warfarin Sodium	Warfarin Sodium	58	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	15
Spironolactone	Spironolactone	56	12
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	52	52
Metformin Hcl Er	Metformin Hcl	52	15
Montelukast Sodium	Montelukast Sodium	52	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	43
Hydralazine Hcl	Hydralazine Hcl	50	13
Duloxetine Hcl	Duloxetine Hcl	49	12
Glipizide	Glipizide	49	14
Mirtazapine	Mirtazapine	47	14
Synthroid	Levothyroxine Sodium	46	14
Trulicity	Dulaglutide	44	suppressed
Bupropion Xl	Bupropion Hcl	43	14
Verapamil Er	Verapamil Hcl	43	12
Eszopiclone	Eszopiclone	38	suppressed
Meclizine Hcl	Meclizine Hcl	35	23
Methylprednisolone	Methylprednisolone	35	33
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	29
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	31	12
Farxiga	Dapagliflozin Propanediol	31	suppressed
Zaleplon	Zaleplon	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Doxepin Hcl	Doxepin Hcl	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	suppressed
Amoxicillin	Amoxicillin	27	24
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	14
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Temazepam	Temazepam	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Fluconazole	Fluconazole	22	11
Ramelteon	Ramelteon	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Ramipril	Ramipril	19	suppressed
Topiramate	Topiramate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Prednisone	Prednisone	17	15
Telmisartan	Telmisartan	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Baclofen	Baclofen	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Colesevelam Hcl	Colesevelam Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Invokana	Canagliflozin	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	13
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Clarithromycin	Clarithromycin	13	11
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Sulindac	Sulindac	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error